Ganymed Pharmaceuticals AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: November 19, 2014
Pages: 18
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G23B6BDC58EEN
Leaflet:

Download PDF Leaflet

Ganymed Pharmaceuticals AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

GANYMED Pharmaceuticals AG (GANYMED) is a biopharmaceutical company. It is involved in developing a new class of therapeutic drugs called Ideal Monoclonal antibodies for the treatment of solid cancers. The company’s pipeline products include IMAB 362, IMAB027, 2nd gen. IMAB, GT468, GT352, GT353 and others. It also performs clinical trials to assess the safety and efficacy of the drugs. Claudetect 18.2 is the company’s proprietary in vitro diagnostic test which allows to assess the expression levels of claudin 18.2 in gastroesophageal, pancreatic, and other solid tumors. It also focuses on the treatment of solid cancers such as testicular, ovarian, uterine, and lungs cancers. GANYMED is headquartered in Mainz, Germany.

Ganymed Pharmaceuticals AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Ganymed Pharma Raises US$60.7 Million In Series E Financing
GANYMED Secures US$82 Million In Venture Financing Round
Acquisition
ATS Beteiligungsverwaltung Acquires Majority Stake In Ganymed Pharma
Ganymed Pharmaceuticals AG - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Key Facts
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Deals By Therapy Area, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Ganymed Pharma Raises US$60.7 Million In Series E Financing
GANYMED Secures US$82 Million In Venture Financing Round
ATS Beteiligungsverwaltung Acquires Majority Stake In Ganymed Pharma
Ganymed Pharmaceuticals AG, Key Competitors
Ganymed Pharmaceuticals AG, Key Employees

LIST OF FIGURES

Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Ganymed Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Skip to top


Ask Your Question

Ganymed Pharmaceuticals AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: